Methylphenidate modulates activity within cognitive neural networks of patients with post-stroke major depression: A placebo-controlled fMRI study

BACKGROUND: Methylphenidate (MP) is a dopamine- and noradrenaline-enhancing agent beneficial for post-stroke depression (PSD) and stroke recovery due to its therapeutic effects on cognition, motivation, and mood; however, the neural mechanisms underlying its clinical effects remain unknown. This stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramasubbu, Rajamannar, Goodyear, Bradley G
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646655/
https://www.ncbi.nlm.nih.gov/pubmed/19337466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646655/
https://www.ncbi.nlm.nih.gov/pubmed/19337466

Ejemplares similares